M&A

Teva makes good on asset-sale vows with $1.1B contraceptive sale
Fierce Pharma
Mon, 09/11/17 - 10:32 pm
Teva Pharmaceutical
CooperSurgical
M&A
contraceptives
Paragard
IUD
5 Tough Questions for Gilead Sciences About the Kite Pharma Acquisition
Motley Fool
Mon, 09/11/17 - 09:17 pm
Gilead Sciences
Kite Pharma
M&A
axi-cel
pay-for-performance
GSK, JnJ and Sanofi: potential buyers of Merck KGaA’s Consumer Health business
GoInPharma
Mon, 09/11/17 - 09:11 pm
GSK
JNJ
Sanofi
Merck KGaA
consumer health
M&A
[video+transcript]Is a Med-Tech Marriage in Mazor Robotics' Future?
Motley Fool
Mon, 09/11/17 - 09:10 am
Mazor Robotics
M&A
Medtronic
devices
AstraZeneca targeting California-based Acadia Pharmaceuticals ($4.4bn)
GoInPharma
Sun, 09/10/17 - 11:34 am
AstraZeneca
M&A
Acadia
Alternative Perspectives On The Biotech M&A Environment
Forbes
Fri, 09/8/17 - 09:31 am
biotech
M&A
R&D
[video+transcript]Are These Healthcare Stocks Top Takeover Targets?
Motley Fool
Thu, 09/7/17 - 07:40 pm
M&A
Juno Therapeutics
Medtronic
Mazor Robotics
devices
5 Things Gilead Sciences' Management Just Said That You'll Want to Know
Motley Fool
Thu, 09/7/17 - 09:40 am
Gilead Sciences
Kite Pharma
HIV
hepatitis C
M&A
Hospital mergers are slowly building monopolies, but regulators rarely intervene
Stat
Thu, 09/7/17 - 09:36 am
hospitals
M&A
J&J Vision closes TearScience buyout
Mass Device
Wed, 09/6/17 - 08:37 pm
JNJ Vision
visual health
TearScience
M&A
devices
Here’s the inside account of Gilead’s 11-week sprint to its $12B Kite buyout
Endpoints
Wed, 09/6/17 - 09:43 am
Gilead Sciences
Kite Pharma
M&A
Merck, looking to build on cancer success, buys I-O biotech Rigontec
Fierce Biotech
Wed, 09/6/17 - 09:20 am
Merck
M&A
Rigontec
biotech
Stryker closes $700m Novadaq buy
Mass Device
Tue, 09/5/17 - 10:20 pm
Stryker
Novadaq
devices
M&A
Abbott tacks another extension on Alere tender offer
Mass Device
Tue, 09/5/17 - 10:10 pm
Abbott Labs
Alere
devices
M&A
Emboldened by recent R&D successes, Merck KGaA looks at selling off $1B-plus consumer division
Endpoints
Tue, 09/5/17 - 11:06 am
R&D
Merck KGaA
consumer health
M&A
Gilead Sciences Couldn't Have Timed its Splash Into CAR-T Better
Motley Fool
Tue, 09/5/17 - 09:28 am
Gilead Sciences
CAR-T
Kite Pharma
M&A
The never-ending process of acquiring Stada
GoInPharma
Mon, 09/4/17 - 10:09 am
Stada
M&A
Bain Capital
Cinven
3 Reasons Gilead Sciences Jumped to Buy Kite Pharma
Motley Fool
Sat, 09/2/17 - 11:13 am
Gilead Sciences
Kite Pharma
M&A
Fresenius closes Merck biosimilar biz purchase
Drug Delivery Business News
Fri, 09/1/17 - 11:08 am
Fresenius
Merck KGaA
biosimilars
M&A
Novartis $475,000 Price Tag Sets the Stage for a Price War With Gilead Sciences
Motley Fool
Thu, 08/31/17 - 10:11 pm
Novartis
CAR-T
Kymriah
Gilead Sciences
Kite Pharma
M&A

Pages